Cipla rating: Purchase approval for Lanreotide, a positive event
The company is likely to gain a healthy market share over the next 12 months, resulting in ~ 6-8% of...
The company is likely to gain a healthy market share over the next 12 months, resulting in ~ 6-8% of...